IP Verse

Pentafarma Sociedade Tecnico Medicinal competitive analysis

Latest oppositions filed by Pentafarma Sociedade Tecnico Medicinal

Explore patent oppositions filed by Pentafarma Sociedade Tecnico Medicinal against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
EP2477611
(Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluormethylphenyl)-Amide Tablet Formulations With Improved StabilitySANOFIJan 4, 2018
EP2801354
Controlled Release Pharmaceutical Compositions Comprising A Fumaric Acid EsterFORWARD PHARMANov 8, 2017
EP2838510
Atomoxetine SolutionELI LILLYJun 21, 2017
EP2251344
Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICADec 27, 2016
EP2465492
Compositions Comprising Sphingosine I Phosphate (Sip) Receptor ModulatorsNOVARTISApr 1, 2016
EP2579852
A Pharmaceutical Spray Composition Comprising A Vitamin D Analogue And A CorticosteroidLEO PHARMASep 28, 2015

Latest PTAB cases involving Pentafarma Sociedade Tecnico Medicinal

Discover the latest PTAB cases involving Pentafarma Sociedade Tecnico Medicinal, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pentafarma Sociedade Tecnico Medicinal with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELI LILLY18331715
FORWARD PHARMA - 18 - -
FWP - 18 - -